A phase II study of atezolizumab as neoadjuvant and adjuvant therapy in patients (pts) with resectable non-small cell lung cancer (NSCLC) Meeting Abstract
| Authors: | Owen, D. H.; Bunn, P. A.; Johnson, B. E.; Kwiatkowski, D. J.; Kris, M. G.; Wistuba, I. I.; Gandhi, M.; Phan, S.; Shames, D. S.; Schulze, K.; Yu, W.; Aisner, D.; Chaft, J. E.; Garon, E. B.; Lee, J. M.; Minna, J. D.; Rusch, V. W.; Reckamp, K. L.; Wozniak, A. J.; Carbone, D. P. |
| Abstract Title: | A phase II study of atezolizumab as neoadjuvant and adjuvant therapy in patients (pts) with resectable non-small cell lung cancer (NSCLC) |
| Meeting Title: | 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 35 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2017 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2017-05-20 |
| Start Page: | 445s |
| Language: | English |
| ACCESSION: | WOS:000411932201157 |
| DOI: | 10.1200/JCO.2017.35.15_suppl.TPS8580 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS8580 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
